References
1. Brown JM, O’Brien SM, Wu C, Sikora JAH, Griffith BP, Gammie JS.
Isolated aortic valve replacement in North America comprising 108,687
patients in 10 years: changes in risks, valve types, and outcomes in the
Society of Thoracic Surgeons National Database. J Thorac
Cardiovasc Surg . 2009;137(1):82-90.
2. Schoen FJ, Levy RJ. Founder’s Award, 25th Annual Meeting of the
Society for Biomaterials, perspectives. Providence, RI, April 28-May 2,
1999. Tissue heart valves: current challenges and future research
perspectives. J Biomed Mater Res . 1999;47(4):439-465.
3. Head SJ, Çelik M, Kappetein AP. Mechanical versus bioprosthetic
aortic valve replacement. Eur Heart J . 2017;38(28):2183-2191.
4. Biancari F, Valtola A, Juvonen T, et al. Trifecta versus Perimount
Magna Ease Aortic Valve Prostheses. Ann Thorac Surg . Published
online February 12, 2020.
5. Kume Y, Fujita T, Fukushima S, et al. Reducing Prosthesis-Patient
Mismatch With Edwards Magna Prosthesis for Aortic Valve Replacement.Circ J Off J Jpn Circ Soc . 2017;81(4):468-475.
6. Fiegl K, Deutsch M-A, Rondak I-C, Lange R, Guenzinger R. Matched
Comparison of Two Different Biological Prostheses for Complete
Supra-annular Aortic Valve Replacement. Thorac Cardiovasc Surg .
2015;63(6):459-466.
7. Nishioka N, Yamada A, Ujihira K, et al. Outcomes of surgical aortic
valve replacement using Carpentier-Edwards PERIMOUNT bioprosthesis
series in elderly patients with severe aortic valve stenosis: a
retrospective cohort study. Gen Thorac Cardiovasc Surg .
2016;64(12):728-734.
8. Wendt D, Thielmann M, Plicht B, et al. The new St Jude Trifecta
versus Carpentier-Edwards Perimount Magna and Magna Ease aortic
bioprosthesis: is there a hemodynamic superiority? J Thorac
Cardiovasc Surg . 2014;147(5):1553-1560.
9. Bach DS, Patel HJ, Kolias TJ, Deeb GM. Randomized comparison of
exercise haemodynamics of Freestyle, Magna Ease and Trifecta
bioprostheses after aortic valve replacement for severe aortic stenosis.Eur J Cardio-Thorac Surg Off J Eur Assoc Cardio-Thorac Surg .
2016;50(2):361-367.
10. Bavaria JE, Desai ND, Cheung A, et al. The St Jude Medical Trifecta
aortic pericardial valve: results from a global, multicenter,
prospective clinical study. J Thorac Cardiovasc Surg .
2014;147(2):590-597.
11. Colli A, Marchetto G, Salizzoni S, et al. The TRIBECA study:
(TRI)fecta (B)ioprosthesis (E)valuation versus (C)arpentier Magna-Ease
in (A)ortic position. Eur J Cardio-Thorac Surg Off J Eur Assoc
Cardio-Thorac Surg . 2016;49(2):478-485.
12. Stock S, Lohmann I, Hanke T, et al. Rest and exercise haemodynamics
in patients with one of two stented bioprostheses and in healthy
controls with small aortic annuli. Interact Cardiovasc Thorac
Surg . 2018;26(3):425-430.
13. Domoto S, Niinami H, Uwabe K, et al. Comparison of early
haemodynamics of 19-mm aortic valve bioprostheses in patients with a
small aortic annulus. Interact Cardiovasc Thorac Surg .
2016;22(1):19-25.
14. Ugur M, Suri RM, Daly RC, et al. Comparison of early hemodynamic
performance of 3 aortic valve bioprostheses. J Thorac Cardiovasc
Surg . 2014;148(5):1940-1946.
15. Yanagawa B, Tam DY, Hong K, et al. Magna Ease Versus Trifecta Early
Hemodynamics: A Systematic Review and Meta-analysis. Innov Phila
Pa . 2018;13(4):267-272.
16. Rubens FD, Gee Y-Y, Ngu JMC, Chen L, Burwash IG. Effect of aortic
pericardial valve choice on outcomes and left ventricular mass
regression in patients with left ventricular hypertrophy. J Thorac
Cardiovasc Surg . 2016;152(5):1291-1298.e2.
17. Goldman S, Cheung A, Bavaria JE, Petracek MR, Groh MA, Schaff HV.
Midterm, multicenter clinical and hemodynamic results for the Trifecta
aortic pericardial valve. J Thorac Cardiovasc Surg .
2017;153(3):561-569.e2.
18. Fukuhara S, Shiomi S, Yang B, et al. Early Structural Valve
Degeneration of Trifecta Bioprosthesis. Ann Thorac Surg .
2020;109(3):720-727.
19. Theologou T, Harky A, Shaw M, et al. Mitroflow and Perimount Magna
10 years outcomes a direct propensity match analysis to assess
reintervention rates and long follow-up mortality. J Card Surg .
2019;34(11):1279-1287.
20. Johnston DR, Soltesz EG, Vakil N, et al. Long-term durability of
bioprosthetic aortic valves: implications from 12,569 implants.Ann Thorac Surg . 2015;99(4):1239-1247.
21. Glaser N, Franco-Cereceda A, Sartipy U. Late survival after aortic
valve replacement with the perimount versus the mosaic bioprosthesis.Ann Thorac Surg . 2014;97(4):1314-1320.
22. Kilic A, Sultan I, Navid F, et al. Trifecta Aortic Bioprosthesis:
Midterm Results in 1,953 Patients From a Single Center. Ann Thorac
Surg . 2019;107(5):1356-1362.
23. Lehmann S, Meyer A, Schroeter T, et al. Midterm Durability and
Hemodynamic Performance of a Third-Generation Bovine Pericardial
Prosthetic Aortic Valve: The Leipzig Experience. Ann Thorac Surg .
2017;103(6):1933-1939.
24. Kalra A, Rehman H, Ramchandani M, et al. Early Trifecta valve
failure: Report of a cluster of cases from a tertiary care referral
center. J Thorac Cardiovasc Surg . 2017;154(4):1235-1240.
25. Kaneyuki D, Nakajima H, Asakura T, et al. Early First-Generation
Trifecta Valve Failure: A Case Series and a Review of the Literature.Ann Thorac Surg . 2020;109(1):86-92.
26. Hernandez-Vaquero D, Diaz R, Pascual I, et al. The Prevalence of
Patient-Prosthesis Mismatch Can Be Reduced Using the Trifecta Aortic
Prosthesis. Ann Thorac Surg . 2018;105(1):144-151.
27. Rodriguez-Gabella T, Voisine P, Puri R, Pibarot P, Rodés-Cabau J.
Aortic Bioprosthetic Valve Durability: Incidence, Mechanisms,
Predictors, and Management of Surgical and Transcatheter Valve
Degeneration. J Am Coll Cardiol . 2017;70(8):1013-1028.
28. Anselmi A, Ruggieri VG, Lelong B, et al. Mid-term durability of the
Trifecta bioprosthesis for aortic valve replacement. J Thorac
Cardiovasc Surg . 2017;153(1):21-28.e1.